Rufinamide in children and adults with Lennox–Gastaut syndrome: First Italian multicenter experience

Abstract

This is the first multicenter Italian experience with rufinamide as an adjunctive drug in children, adolescents and adults with Lennox-Gastaut syndrome. The patients were enrolled in a prospective, add-on, open-label treatment study from 11 Italian centers for children and adolescent epilepsy care. Forty-three patients (26 males, 17 females), aged between 4… (More)
DOI: 10.1016/j.seizure.2010.09.008

Topics

3 Figures and Tables

Cite this paper

@article{Coppola2010RufinamideIC, title={Rufinamide in children and adults with Lennox–Gastaut syndrome: First Italian multicenter experience}, author={Giangennaro Coppola and Salvatore Grosso and Emilio Franzoni and Pierangelo Veggiotti and Nelia Zamponi and Pasquale Parisi and A Spalice and Francesco Habetswallner and Antonio Fels and Giuseppe Capovilla and Alberto Verrotti and Salvatore Mangano and Alberto Balestri and Paolo Curatolo and Antonio Pascotto}, journal={Seizure}, year={2010}, volume={19}, pages={587-591} }